Ability Pharmaceuticals, SL announced today that Carles Domènech, PhD, Chief Executive Officer and co-Founder, will be attending the 4th BIOMED EVENT® by INVEST SECURITIES on Tuesday, January 22, 2019 in Paris. The conference is highly transactional, bringing together an exciting cross-section of small-cap venture-funded companies with leading investors, pharmas, and investment service providers.

Besides that, Hector Perez-Montoyo, PhD,  Biological Research Director, is attending the 2019 Cholangiocarcinoma Foundation Annual Conference from January 30th to February 2nd, 2019 in Salt Lake City, Utah, USA. The Cholangiocarcinoma Foundation's annual program seeks to develop sustainable participation of the medical and research communities in the field of cholangiocarcinoma.